Fortress Biotech Inc (FBIO) Stock Price, Quote & News

Company Profile

Fortress Biotech, Inc., together with its subsidiaries, operates as a biopharmaceutical company in the United States and internationally. The company offers Emrosi, a minocycline hydrochloride extended-release capsule for the treatment of rosacea; Qbrexza a medicated cloth towelette for the treatment of axillary hyperhidrosis; Accutane, an oral isotretinoin drug for the treatment of severe recalcitrant nodular acne; Amzeeq, a minocycline topical foam for the treatment of lesions of non-nodular m...

Industry: Biotechnology

Sector: Healthcare

Phone: 781 652 4500

Website: www.fortressbiotech.com

Address:

1111 Kane Concourse, Suite 301, Bay Harbor Islands, United States

braves1983 Aug. 24 at 12:11 PM

$FBIO back to 2.80. Seems like we just stuck in 2.80s

0 · Reply

Henry20feb_ Aug. 23 at 7:40 AM

$FBIO Institutional holders +3 → institutional long shares roughly +13% → several new positions → improving Fortress fundamentals at the same time.

0 · Reply

drose0527 Aug. 22 at 12:13 AM

$FBIO I think our big push is coming next week. I would think we try and push through both moving Averages at 3. Looking for price to push back through the trend line on Monday. Tuesday we will extend off of that trend line into the 3.00’s over taking the 2 above moving averages. Wednesday could be a pause day. As Monday. And Tuesday got us over the hump

1 · Reply

Henry20feb_ Aug. 21 at 9:16 AM

$FBIO Journey Medical’s Q2 was clearly positive for FBIO: Emrosi is growing strongly while Journey reached positive adjusted EBITDA, showing that the subsidiary is moving toward becoming a self-sustaining commercial business rather than a financing burden. This strengthens FBIO’s underlying value base and makes its pipeline catalysts increasingly look like upside on top of a more stable commercial foundation.

1 · Reply

braves1983 Aug. 20 at 8:01 PM

$FBIO wi this ever be green??? Ever

0 · Reply

braves1983 Aug. 20 at 5:34 PM

$FBIO love being red everyday here every day. It’s fucking sad. I want out so fucking bad. Just get to $3. I can’t stand having dog shit in my portfolio

0 · Reply

unmvar Aug. 20 at 5:06 PM

$FBIO would have been good to move from here to $DERM. $FBIO doesn't move the needle despite $DERM making progress

2 · Reply

braves1983 Aug. 20 at 2:45 PM

$FBIO just keeps going down and down.

0 · Reply

CapitalMonk Aug. 20 at 12:31 AM

$FBIO Price: $2.85 (-2.06%) Trend: Bullish Market Bias (7D): Bearish Bias 📉 Expected Range: ±0.97% RSI: 36.7 | Momentum: Strong Downside Volume: -28.7% vs avg Volatility: 4.42% Support: $2.57 | Resistance: $3.59 Data and analytics sourced from Thescanner educational research https://www.thescanner.ai

0 · Reply

hafstein Aug. 19 at 9:08 PM

$FBIO Moderna got 200% up only today with cancer vaccine approval and this manipulated garbage with the old dying CEO intentionally crash it after every catalyst , approval, PRV, strong earnings. Never wnet up after any of these. Always crash. 😏

0 · Reply

Fortress Biotech Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights

FBIOP

Aug 12, 2026, 4:30 PM EDT - 11 days ago

Fortress Biotech Earnings Call Transcript: Q2 2026

Aug 12, 2026, 4:30 PM EDT - 11 days ago

Fortress Biotech Earnings release: Q2 2026

Aug 12, 2026, 4:30 PM EDT - 11 days ago

Fortress Biotech Quarterly report: Q2 2026

Aug 12, 2026, 4:01 PM EDT - 11 days ago

Market Cap	95.72M
Revenue (ttm)	63.26M
Net Income (ttm)	6.82M
EPS (ttm)	N/A
PE Ratio	1.05
Forward PE	N/A
Profit Margin	10.78%
Debt to Equity Ratio	0.17

Volume	321,629
Avg Vol	641,368
Day's Range	N/A - N/A
Shares Out	33.35M
Stochastic %K	62%
Beta	1.21
Analysts	Strong Sell
Price Target	$11.00